Prophylactic intravenous paracetamol use in extremely premature infants for patent ductus arteriosus.
Musa SilahliZeynel GokmenMehmet TekinPublished in: Journal of basic and clinical physiology and pharmacology (2020)
The results of the study indicated that prophylactic paracetamol use in ELBW infants decreases the likelihood of hsPDA. The repeated course of ibuprofen for the treatment of hsPDA can be reduced. Furthermore, it can be understood that while prophylactic use of paracetamol is preventive for intraventricular hemorrhage, it does not function in the same way for retinopathy of prematurity or bronchopulmonary dysplasia. It might even worse the retinopathy of prematurity. Further prospective randomized controlled and larger sample-sized studies are needed.